Medicare Enrolled
Dr. Paul Piper, MD
Endocrinology · The Woodlands, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Piper from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Piper? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Piper
Dr. Paul Piper is an endocrinology in The Woodlands, TX, with 19 years in practice. Based on federal Medicare data, Dr. Piper performed 26,297 Medicare services across 2,436 unique beneficiaries.
Between the years covered by Open Payments, Dr. Piper received a total of $22,337 from 81 pharmaceutical and/or device companies across 1192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Piper is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 1% volume in TX$ $22,337 industry payments
Medicare Practice Summary
Medicare Utilization ↗26,297
Medicare services
Top 1% in TX for endocrinology
2,436
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,384 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 19,325 | $8 | $26 |
| Denosumab injection (Prolia/Xgeva) | 3,060 | $18 | $46 |
| Office visit, established patient (30-39 min) | 1,148 | $88 | $330 |
| Injection, zoledronic acid, 1 mg | 380 | $6 | $105 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 303 | $26 | $133 |
| Comprehensive metabolic blood panel | 280 | $10 | $43 |
| Hemoglobin A1c test (diabetes monitoring) | 220 | $10 | $40 |
| Free thyroxine (T4) test | 208 | $9 | $37 |
| Thyroid stimulating hormone (TSH) test | 205 | $16 | $69 |
| Drug injection, under skin or into muscle | 185 | $10 | $105 |
| Lipid panel (cholesterol and triglycerides) | 169 | $13 | $55 |
| New patient office visit (45-59 min) | 137 | $120 | $505 |
| Blood draw (venipuncture) | 105 | $8 | $10 |
| Ultrasound scan of head and neck soft tissue | 87 | $81 | $356 |
| Complete blood count (CBC) with differential | 82 | $8 | $32 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 77 | $46 | $213 |
| Parathyroid hormone level test | 70 | $40 | $169 |
| Vitamin D level test | 60 | $29 | $111 |
| Flu vaccine administration | 59 | $30 | $77 |
| Flu vaccine, quadrivalent | 54 | $76 | $183 |
| Office visit, established patient (20-29 min) | 28 | $70 | $222 |
| Phosphate level test | 24 | $5 | $19 |
| Thyroid hormone, t3 measurement, total | 16 | $14 | $58 |
| Initial hospital admission, high complexity | 15 | $134 | $625 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
87.6% medium
12.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,337
Total received (2018-2024)
Avg $3,191/year across 7 years
Top 20% in TX for endocrinology
81
Companies
1,192
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,237 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,722
2023$2,996
2022$3,982
2021$4,255
2020$2,961
2019$3,422
2018$1,999
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$1,874
SANOFI-AVENTIS U.S. LLC
$1,693
AstraZeneca Pharmaceuticals LP
$1,482
Lilly USA, LLC
$1,421
Corcept Therapeutics
$1,297
Amgen Inc.
$1,247
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,212
Mannkind Corporation
$865
Zealand Pharma US, Inc.
$862
MannKind Corporation
$567
Radius Health, Inc.
$555
Xeris Pharmaceuticals, Inc.
$515
Abbott Laboratories
$497
Merck Sharp & Dohme Corporation
$458
Medtronic, Inc.
$383
Companion Medical, Inc.
$380
Bayer HealthCare Pharmaceuticals Inc.
$368
Endo Pharmaceuticals Inc.
$354
Esperion Therapeutics, Inc.
$330
Tandem Diabetes Care, Inc.
$325
Dexcom, Inc.
$318
Novartis Pharmaceuticals Corporation
$300
Insulet Corporation
$289
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$273
Becton, Dickinson and Company
$249
IBSA Pharma Inc.
$242
CeQur Corporation
$210
Horizon Therapeutics plc
$197
RECORDATI_RARE_DISEASES_INC.
$190
ABBVIE INC.
$186
Amarin Pharma Inc.
$185
Antares Pharma, Inc.
$175
Shire North American Group Inc
$171
Kyowa Kirin, Inc.
$159
Janssen Pharmaceuticals, Inc
$138
DEXCOM, INC.
$114
Medtronic MiniMed, Inc.
$101
Amphastar Pharmaceuticals, Inc.
$99
Alexion Pharmaceuticals, Inc.
$99
AbbVie Inc.
$98
Averitas Pharma Inc.
$96
Endo USA, Inc.
$95
Intuity Medical Inc
$89
Acerus Pharmaceuticals Corporation
$88
Valeritas, Inc.
$81
VIVUS LLC
$79
Bayer Healthcare Pharmaceuticals Inc.
$78
Currax Pharmaceuticals LLC
$74
Neurocrine Biosciences, Inc.
$73
AbbVie, Inc.
$72
Ultragenyx Pharmaceutical Inc.
$67
Supernus Pharmaceuticals, Inc.
$62
Merck Sharp & Dohme LLC
$59
Amneal Pharmaceuticals LLC
$59
EISAI INC.
$55
Clarus Therapeutics Inc.
$50
Rhythm Pharmaceuticals, Inc.
$47
Ipsen Biopharmaceuticals, Inc
$45
BOSTON SCIENTIFIC CORPORATION
$41
Bigfoot Biomedical Inc
$40
Nevro Corp.
$39
EUSA Pharma (US) LLC
$38
BETA BIONICS, INC.
$37
VIVUS, Inc.
$37
LifeScan, Inc.
$34
Embecta Corp.
$31
Nalpropion Pharmaceuticals LLC
$29
Echosens North America, Inc.
$28
Althera Pharmaceuticals LLC
$28
Ascensia Diabetes Care Us Inc.
$22
Roche Diabetes Care, Inc.
$21
Ascendis Pharma Inc
$21
GRT US Holding, Inc.
$21
Kowa Pharmaceuticals America, Inc.
$21
Amryt Pharma Holdings Ltd
$20
Takeda Pharmaceuticals U.S.A., Inc.
$16
Acella Pharmaceuticals, LLC
$15
Tolmar, Inc.
$15
Optos, Inc.
$13
Strongbridge US INC.
$12
Regeneron Healthcare Solutions, Inc.
$12
Top 3 companies account for 22.6% of total payments
Associated products mentioned in payments ›
AFREZZA · AVEED · Androgel · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · Belviq · CONTRAVE · CYCLOSET · CeQur Simplicity · Crysvita · Cryvista · DC ACCU-CHEK Aviva Connect Kits and Accessories · DEXCOM CGM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE E3 SMART TRANSMITTER KIT · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · FreeStyle Lite system · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · Imcivree · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LYUMJEV · Livalo · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 630G · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid 60 · Natesto · NovoLog · OTREXUP · Omnipod · OneTouch · Otrexup · Ozempic · PANORAMIC OPHTHALMOSCOPE · PRALUENT · PROCLAIM · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · QUTENZA · Qsymia · Qutenza · RECORLEV · RYBELSUS · Repatha · Roszet · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · STEGLUJAN · SYNTHROID · Saxenda · Senza · Senza Spinal Cord Stimulation System · Strensiq · Sylvant · Synthroid · TEPEZZA · TESTOPEL · TLANDO · TOUJEO · TRULICITY · TZIELD · Tirosint · Tymlos · UBRELVY · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Victoza · WAVEWRITER ALPHA · Wegovy · XIAFLEX · XYOSTED · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $85 per 100 Medicare services performed
Geographic Context
Endocrinologys within 10 mi
27
Per 100K population
4.1
County median income
$97,266
Nearest hospital
ST LUKE'S THE WOODLANDS HOSPITAL
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Piper is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (low-engagement, top 20%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Piper experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Piper performed 19,325 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Piper receive payments from pharmaceutical companies?
Yes. Dr. Piper received a total of $22,337 from 81 companies across 1,192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Piper's costs compare to other endocrinologys in The Woodlands?
Dr. Piper's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Piper) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologys in The Woodlands
Browse endocrinologys in The Woodlands ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologys in TX
Endocrinologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologys in TX
Which TX endocrinologys receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology